Stay updated on SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial

Sign up to get notified when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T20:42:04.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the efficacy and safety evaluation of sequential pembrolizumab and accelerated, dose-painted radiotherapy for patients with locally advanced NSCLC with PD-L1 expression ≥ 50% in the Phase II trial.
    Difference
    0.1%
    Check dated 2024-06-06T14:16:28.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria 6' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' providing examples such as a person's general health condition or prior treatments. This change likely pertains to medical and healthcare-related publications and documentation.
    Difference
    47%
    Check dated 2024-05-22T19:37:13.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map' on the webpage, indicating a change in the type of intervention being highlighted. This change may be related to medical and healthcare-related publications and documentation.
    Difference
    1.0%
    Check dated 2024-05-01T17:56:29.000Z thumbnail image

Stay in the know with updates to SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.